Expression of Th2-skewed pathology mediators in monocyte-derived type 2 of dendritic cells (DC2)

Immunology Letters

Volumn 126, Issue 1-2, 2009, Pages 29-36

  Hata, Mitsumi ^a,b   Takahara, Seiji ^a   Tsuzaki, Hidetoshi ^a   Ishii, Yoshiki ^b   Nakata, Koh ^c   Akagawa, Kiyoko S ^d   Satoh, Kazuki ^a  

^a DAIICHI SANKYO CO   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

cDNA subtraction; Dendritic cells; Monocytes; mRNA expression; Na ve T cell; Th1 Th2 cells

Indexed keywords

ALPHA E INTEGRIN; ARACHIDONATE 15 LIPOXYGENASE; ATP BINDING CASSETTE SUBFAMILY C MEMBER 3; CELL PROTEIN; CHOLESTANETRIOL 26 MONOOXYGENASE; FIBRONECTIN 1; FORMYLPEPTIDE RECEPTOR LIKE 2; GLYCOPROTEIN NMB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR SUBFAMILY B MEMBER 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEUTROPHIL CYTOSOLIC FACTOR 2; OSTEONECTIN; PHOSPHATIDIC ACID PHOSPHATASE TYPE 2B; RADICAL ADENOSYLMETHIONINE DOMAIN CONTAINING 2; SERPIN PEPTIDASE INHIBITOR CLADE E MEMBER 1; STABILIN 1; THROMBOXANE A SYNTHASE 1; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; PRIORITY JOURNAL; TH2 CELL; UPREGULATION;

ANTIGENS, CD; ANTIGENS, CD86; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOCHROME P-450 CYP27A1; DENDRITIC CELLS; FIBRONECTINS; GENE EXPRESSION PROFILING; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOGLOBULINS; INTEGRIN ALPHA CHAINS; INTERFERON-GAMMA; INTERLEUKIN-3; INTERLEUKIN-4; INTERLEUKIN-5; LYMPHOCYTE CULTURE TEST, MIXED; MEMBRANE GLYCOPROTEINS; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 70249093566     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.07.008     Document Type: Article

References (59)

1. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
2. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 18 (2000) 767-811
3. Moser M., and Murphy K.M. Dendritic cell regulation of TH1-TH2 development. Nat Immunol 1 (2000) 199-205
4. Lanzavecchia A., and Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 106 (2001) 263-266
5. Eisenbarth S.C., Piggott D.A., and Bottomly K. The master regulators of allergic inflammation: dendritic cells in Th2 sensitization. Curr Opin Immunol 15 (2003) 620-626
6. Ito T., Liu Y.J., and Kadowaki N. Functional diversity and plasticity of human dendritic cell subsets. Int J Hematol 81 (2005) 188-196
7. Akagawa K., Takasuka N., and Sakurai T. IL-4 stimulates the generation of dendritic cells and multinucleated giant cells from human monocytes. Lymphokine Cytokine Res 12 (1993) 326
8. Sallusto F., and Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage-colony-stimulating factor plus interleukin 4 and down regulated by tumor necrosis factor α. J Exp Med 179 (1994) 1109-1118
9. + dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood 88 (1996) 4029-4039
10. Bender A., Sapp M., Schuler G., Steinman R.M., and Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 196 (1996) 121-135
11. Romani N., Reider D., Heuer M., Ebner S., Kampgen E., Eibl B., et al. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J Immunol Methods 196 (1996) 137-151
12. Grouard G., Rissoan M.C., Filgueira L., Durand I., Banchereau J., and Liu Y.J. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 185 (1997) 1101-1111
13. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal Malefyt R., et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283 (1999) 1183-1186
14. Rissoan M.C., Duhen T., Bridon J.M., Bendriss-Vermare N., Peronne C., de Saint Vis B., et al. Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood 100 (2002) 3295-3303
15. Ebner S., Hofer S., Nguyen V.A., Furhapter C., Herold M., Fritsch P., et al. A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern. J Immunol 168 (2002) 6199-6207
16. Hilkens C.M., Kalinski P., de Boer M., and Kapsenberg M.L. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 90 (1997) 1920-1926
17. Jotwani R., Pulendran B., Agrawal S., and Cutler C.W. Human dendritic cells respond to Porphyromonas gingivalis LPS by promoting a Th2 effector response in vitro. Eur J Immunol 33 (2003) 2980-2986
18. Gagliardi M.C., Sallusto F., Marinaro M., Langenkamp A., Lanzavecchia A., and De Magistris M.T. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. Eur J Immunol 30 (2000) 2394-2403
19. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., et al. Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat Immunol 3 (2002) 673-680
20. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I., and Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med 189 (1999) 821-829
21. -/- setting. Immunity 16 (2002) 429-439
22. Lutz M.B. IL-3 in dendritic cell development and function: a comparison with GM-CSF and IL-4. Immunobiology 209 (2004) 79-87
23. Kajino K., Nakamura I., Bamba H., Sawai T., and Ogasawara K. Involvement of IL-10 in exhaustion of myeloid dendritic cells and rescue by CD40 stimulation. Immunology 120 (2007) 28-37
24. H2 and nonpolarized T cells. Nat Immunol 1 (2000) 311-316
25. Thurnher M. Lipids in dendritic cell biology: messengers, effectors, and antigens. J Leukoc Biol 81 (2007) 154-160
26. Becky Kelly E.A., Busse W.W., and Jarjour N.N. A comparison of the airway response to segmental antigen bronchoprovocation in atopic asthma and allergic rhinitis. J Allergy Clin Immunol 111 (2003) 79-86
27. Terada M., Kelly E.A., and Jarjour N.N. Increased thrombin activity after allergen challenge: a potential link to airway remodeling?. Am J Respir Crit Care Med 169 (2004) 373-377
28. Xiao W., Hsu Y.P., Ishizaka A., Kirikae T., and Moss R.B. Sputum cathelicidin, urokinase plasminogen activation system components, and cytokines discriminate cystic fibrosis, COPD, and asthma inflammation. Chest 128 (2005) 2316-2326
29. Chu E.K., Cheng J., Foley J.S., Mecham B.H., Owen C.A., Haley K.J., et al. Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells. Am J Respir Cell Mol Biol 35 (2006) 628-638
30. Sung S.S., Fu S.M., Rose Jr. C.E., Gaskin F., Ju S.T., and Beaty S.R. A major lung CD103 (alphaE)-beta 7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol 176 (2006) 2161-2172
31. Ripoll V.M., Irvine K.M., Ravasi T., Sweet M.J., and Hume D.A. Gpnmb is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses. J Immunol 178 (2007) 6557-6566
32. Kang H.K., Lee H.Y., Kim M.K., Park K.S., Park Y.M., Kwak J.Y., et al. The synthetic peptide Trp-Lys-Tyr-Met-Val-d-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2. J Immunol 175 (2005) 685-692
33. Cella M., Jarrossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A., et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 5 (1999) 919-923
34. + regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 106 (2005) 3490-3497
35. S cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3 (2002) 237-243
36. Cho S.H., Ryu C.H., and Oh C.K. Plasminogen activator inhibitor-1 in the pathogenesis of asthma. Exp Biol Med 229 (2004) 138-146
37. Pampuch A., Kowal K., Bodzenta-Lukaszyk A., Di Castelnuovo A., Chyczewski L., Donati M.B., et al. The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients. Allergy 61 (2006) 234-238
38. Sejima T., Madoiwa S., Mimuro J., Sugo T., Okada K., Ueshima S., et al. Protection of plasminogen activator inhibitor-1-deficient mice from nasal allergy. J Immunol 174 (2005) 8135-8143
39. Wenzel S.E., Westcott J.Y., and Larsen G.L. Bronchoalveolar lavage fluid mediator levels 5 min after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses. J Allergy Clin Immunol 87 (1991) 540-548
40. Oosterhoff Y., Kauffman H.F., Rutgers B., Zijlstra F.J., Koeter G.H., and Postma D.S. Inflammatory cell number and mediators in bronchoalveolar lavage fluid and peripheral blood in subjects with asthma with increased nocturnal airways narrowing. J Allergy Clin Immunol 96 (1995) 219-229
41. Dogne J.M., de Leval X., Benoit P., Delarge J., and Masereel B. Thromboxane A2 inhibition: therapeutic potential in bronchial asthma. Am J Respir Med 1 (2002) 11-17
42. Bradding P., Redington A.E., Djukanovic R., Conrad D.J., and Holgate S.T. 15-Lipoxygenase immunoreactivity in normal and in asthmatic airways. Am J Respir Crit Care Med 151 (1995) 1201-1204
43. Chu H.W., Balzar S., Westcott J.Y., Trudeau J.B., Sun Y., Conrad D.J., et al. Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy 32 (2002) 1558-1565
44. Laprise C., Sladek R., Ponton A., Bernier M.C., Hudson T.J., and Laviolette M. Functional classes of bronchial mucosa genes that are differentially expressed in asthma. BMC Genomics 5 (2004) 21-30
45. Hajek A.R., Lindley A.R., Favoreto Jr. S., Carter R., Schleimer R.P., and Kuperman D.A. 12/15-Lipoxygenase deficiency protects mice from allergic airways inflammation and increases secretory IgA levels. J Allergy Clin Immunol 122 (2008) 633-639
46. Andersson C.K., Claesson H.E., Rydell-Tormanen K., Swedmark S., Hallgren A., and Erjefalt J.S. Mice lacking 12/15-lipoxygenase have attenuated airway allergic inflammation and remodeling. Am J Respir Cell Mol Biol 39 (2008) 648-656
47. Aliberti J., Hieny S., Reis e Sousa C., Serhan C.N., and Sher A. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat Immunol 3 (2002) 76-82
48. Kim T.B., Kim S.Y., Moon K.A., Park C.S., Jang M.K., Yun E.S., et al. Five-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates poly (I:C)-induced airway inflammation in a murine model of asthma. Clin Exp Allergy 37 (2007) 1709-1719
49. Proudfoot A.E. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2 (2002) 106-115
50. Horai R., Saijo S., Tanioka H., Nakae S., Sudo K., Okahara A., et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 191 (2000) 13-20
51. Shepherd J., and Nicklin M.J. Elastic-vessel arteritis in interleukin-1 receptor antagonist-deficient mice involves effector Th1 cells and requires interleukin-1 receptor. Circulation 11 (2005) 3135-3140
52. Hur W., Cho M.L., Yoon S.K., Kim S.Y., Ju J.H., Jhun J.Y., et al. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice. Immunol Lett 106 (2006) 154-162
53. Kzhyshkowska J., Workman G., Cardó-Vila M., Arap W., Pasqualini R., Gratchev A., et al. Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC. J Immunol 176 (2006) 5825-5832
54. Youssef S., Stuve O., Patarroyo J.C., Ruiz P.J., Radosevich J.L., Hur E.M., et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420 (2002) 78-84
55. Axelson M., and Larsson O. Low density lipoprotein (LDL) cholesterol is converted to 27-hydroxycholesterol in human fibroblasts. J Biol Chem 270 (1995) 15102-15110
56. Javitt N.B. 25R,26-Hydroxycholesterol revisited: synthesis, metabolism, and biologic roles. J Lipid Res 43 (2002) 665-670
57. Toews M.L., Ediger T.L., Romberger D.J., and Rennard S.I. Lysophosphatidic acid in airway function and disease. Biochim Biophys Acta 1582 (2002) 240-250
58. Georas S.N., Berdyshev E., Hubbard W., Gorshkova I.A., Usatyuk P.V., Saatian B., et al. Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challenge. Clin Exp Allergy 37 (2007) 311-322
59. Urosevic M., Dummer R., Conrad C., Beyeler M., Laine E., Burg G., et al. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. J Natl Cancer Inst 97 (2005) 1143-1153